379 related articles for article (PubMed ID: 17728334)
1. The relationship of dyspnoea to function and quality of life in systemic sclerosis.
Baron M; Sutton E; Hudson M; Thombs B; Markland J; Pope J; Robinson D; Jones N; Docherty P; Abu-Hakima M; LeClercq S; Smith D; Mathieu JP
Ann Rheum Dis; 2008 May; 67(5):644-50. PubMed ID: 17728334
[TBL] [Abstract][Full Text] [Related]
2. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
[TBL] [Abstract][Full Text] [Related]
3. Validity of the Saint George's Respiratory Questionnaire in the evaluation of the health-related quality of life in patients with interstitial lung disease secondary to systemic sclerosis.
Beretta L; Santaniello A; Lemos A; Masciocchi M; Scorza R
Rheumatology (Oxford); 2007 Feb; 46(2):296-301. PubMed ID: 16877463
[TBL] [Abstract][Full Text] [Related]
4. Clinical correlates of quality of life in systemic sclerosis measured with the World Health Organization Disability Assessment Schedule II.
Hudson M; Thombs BD; Steele R; Watterson R; Taillefer S; Baron M;
Arthritis Rheum; 2008 Feb; 59(2):279-84. PubMed ID: 18240196
[TBL] [Abstract][Full Text] [Related]
5. Gender-associated differences in dyspnoea and health-related quality of life in patients with chronic obstructive pulmonary disease.
Katsura H; Yamada K; Wakabayashi R; Kida K
Respirology; 2007 May; 12(3):427-32. PubMed ID: 17539850
[TBL] [Abstract][Full Text] [Related]
6. Clinical correlates of self-reported physical health status in systemic sclerosis.
Hudson M; Steele R; Lu Y; Thombs BD; Panopalis P; Baron M;
J Rheumatol; 2009 Jun; 36(6):1226-9. PubMed ID: 19447939
[TBL] [Abstract][Full Text] [Related]
7. Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey.
Rannou F; Poiraudeau S; Berezné A; Baubet T; Le-Guern V; Cabane J; Guillevin L; Revel M; Fermanian J; Mouthon L
Arthritis Rheum; 2007 Feb; 57(1):94-102. PubMed ID: 17266096
[TBL] [Abstract][Full Text] [Related]
8. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
Garin MC; Highland KB; Silver RM; Strange C
J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
[TBL] [Abstract][Full Text] [Related]
9. Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial.
Khanna D; Furst DE; Clements PJ; Park GS; Hays RD; Yoon J; Korn JH; Merkel PA; Rothfield N; Wigley FM; Moreland LW; Silver R; Steen VD; Weisman M; Mayes MD; Collier DH; Medsger TA; Seibold JR; ;
J Rheumatol; 2005 May; 32(5):832-40. PubMed ID: 15868618
[TBL] [Abstract][Full Text] [Related]
10. Quality of life in systemic sclerosis: psychometric properties of the World Health Organization Disability Assessment Schedule II.
Hudson M; Steele R; Taillefer S; Baron M;
Arthritis Rheum; 2008 Feb; 59(2):270-8. PubMed ID: 18240187
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life in systemic sclerosis as measured by the Short Form 36: relationship with clinical and biologic markers.
Del Rosso A; Boldrini M; D'Agostino D; Placidi GP; Scarpato A; Pignone A; Generini S; Konttinen Y; Zoppi M; Vlak T; Placidi G; Matucci-Cerinic M
Arthritis Rheum; 2004 Jun; 51(3):475-81. PubMed ID: 15188336
[TBL] [Abstract][Full Text] [Related]
12. Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study.
Khanna D; Yan X; Tashkin DP; Furst DE; Elashoff R; Roth MD; Silver R; Strange C; Bolster M; Seibold JR; Riley DJ; Hsu VM; Varga J; Schraufnagel DE; Theodore A; Simms R; Wise R; Wigley F; White B; Steen V; Read C; Mayes M; Parsley E; Mubarak K; Connolly MK; Golden J; Olman M; Fessler B; Rothfield N; Metersky M; Clements PJ;
Arthritis Rheum; 2007 May; 56(5):1676-84. PubMed ID: 17469162
[TBL] [Abstract][Full Text] [Related]
13. The impact of psychological functioning upon systemic sclerosis patients' quality of life.
Hyphantis TN; Tsifetaki N; Siafaka V; Voulgari PV; Pappa C; Bai M; Palieraki K; Venetsanopoulou A; Mavreas V; Drosos AA
Semin Arthritis Rheum; 2007 Oct; 37(2):81-92. PubMed ID: 17512572
[TBL] [Abstract][Full Text] [Related]
14. Quality of life in patients with systemic sclerosis compared to the general population and patients with other chronic conditions.
Hudson M; Thombs BD; Steele R; Panopalis P; Newton E; Baron M;
J Rheumatol; 2009 Apr; 36(4):768-72. PubMed ID: 19228662
[TBL] [Abstract][Full Text] [Related]
15. Impact of pain in health related quality of life of patients with systemic sclerosis.
Georges C; Chassany O; Toledano C; Mouthon L; Tiev K; Meyer O; Ilie D; Rambeloarisoa J; Marjanovic Z; Cabane J; Sereni D; Pouchot J; Farge D
Rheumatology (Oxford); 2006 Oct; 45(10):1298-302. PubMed ID: 16754629
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease.
Trad S; Amoura Z; Beigelman C; Haroche J; Costedoat N; Boutin le TH; Cacoub P; Frances C; Wechsler B; Grenier P; Piette JC
Arthritis Rheum; 2006 Jan; 54(1):184-91. PubMed ID: 16385514
[TBL] [Abstract][Full Text] [Related]
17. The presence of anti-centromere antibodies may predict progression of estimated pulmonary arterial systolic pressure in systemic sclerosis.
Kampolis C; Plastiras S; Vlachoyiannopoulos P; Moyssakis I; Tzelepis G
Scand J Rheumatol; 2008; 37(4):278-83. PubMed ID: 18612928
[TBL] [Abstract][Full Text] [Related]
18. Quality of life and functional status in systemic sclerosis compared to other rheumatic diseases.
Johnson SR; Glaman DD; Schentag CT; Lee P
J Rheumatol; 2006 Jun; 33(6):1117-22. PubMed ID: 16622903
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of disease-specific health-related quality of life in patients with pulmonary arterial hypertension.
Zlupko M; Harhay MO; Gallop R; Shin J; Archer-Chicko C; Patel R; Palevsky HI; Taichman DB
Respir Med; 2008 Oct; 102(10):1431-8. PubMed ID: 18617379
[TBL] [Abstract][Full Text] [Related]
20. Assessment of health-related quality of life in patients treated with hemodialysis in Serbia: influence of comorbidity, age, and income.
Stojanovic M; Stefanovic V
Artif Organs; 2007 Jan; 31(1):53-60. PubMed ID: 17209961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
